While retinal thinning may serve as a biomarker for neurodegeneration, it is unclear if retinal Aβ or tau deposits can differentiate AD from normal aging105 (Table 1; for animal studies, see Guo et al106). This evidence concerns the gene MAPT and Alzheimer disease.